NCT07512843Completed
Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With Schizophrenia
Evaluation of the Feasibility, Acceptability, and Preliminary Efficacy of a Group Reminiscence Intervention in a Sample of Inpatients With Schizophrenia
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
The study aimed to test whether group reminiscence intervention for inpatients with schizophrenia is feasible, acceptable and preliminary effective. The effect of the intervention was evaluated on cognition, communication, and social function. Phase I was a multi-phase parallel study (n=38). The purpose of the study was to assess feasibility and preliminary efficacy by conducting an 8-week intervention with the participants. The study employed a single-group pretest-posttest evaluation. Phase II evaluated acceptability and performed a thematic analysis of semi-structured interviews conducted by a purposively selected subsample (N=8).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 38 (actual)
- First submitted
- 28 Mar 2026
- Start date
- 1 Feb 2025
- Primary completion date
- 29 Aug 2025
- Lead sponsor
- The Hashemite University
- Diseases
- Schizophrenia
- NCT number
- NCT07512843
What you commit to
- Study type: Interventional
- Participants enrolled: 38
- From 1 Feb 2025 to the primary completion date, 29 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe cognitive impairment or intellectual disability
- Acute psychiatric symptoms or suicidal ideation
Who the study is looking for
- Adults aged 18-65 with schizophrenia diagnosed by DSM-5-TR
- Clinically stable, no acute episode or hospitalization in past 30 days
- Adequate cognition, passed MMSE, able to engage and provide consent
- Able to attend group sessions and participate in reminiscence sessions
Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Hashemite University Coordinator of this site? Confirm its status | Zarqa | Jordan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.